[Clinical experiences with the use of Oxycell (polyanhydroglucuronic acid) in the field of otorhinolaryngology].
D005965:Glucuronates / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D008441:Maxillary Neoplasms / Q000601:surgery; D009668:Nose Diseases / Q000601:surgery; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D011182:Postoperative Care; D012852:Sinusitis / Q000601:surgery; D014068:Tonsillectomy
D005965:Glucuronates; D006490:Hemostatics